Market Overview

Charles River Labs Closes Purchase of Majority Ownership of Vital River

Share:
Related CRL
Jefferies Boosts Targets Across Pharmaceutical Service Stocks
Benzinga's Top Upgrades
Carl Appoints Rick Sanderson to the Board of Directors (GuruFocus)

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed its acquisition of a 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.

Posted-In: News M&A

 

Related Articles (CRL)

Around the Web, We're Loving...

Get Benzinga's Newsletters